芽胞杆菌治疗幽门螺杆菌感染疗效的Meta分析

目的评价芽胞杆菌(Bacillus)联合根除标准疗法治疗幽门螺杆菌(H.pylori)感染的有效性。方法收集关于芽胞杆菌联合治疗H.pylori感染的随机对照试验(RCT),检索时限为建库至2020年5月;对符合纳入标准的研究进行偏倚风险评价及Meta分析。结果最终纳入14个RCT。Meta分析结果显示芽胞杆菌联合治疗能提高H.pylori根除率(ITT分析:RR=1.13,95%CI:1.08~1.18,P0.001;PP分析:RR=1.13,95%CI:1.09~1.17,P0.001),降低不良反应发生率(RR=0.42,95%CI:0.35~0.50,P0.001)。根据亚组分析结果,芽胞杆菌联合H.pylori两种常规治疗方案[三联疗法(RR=1.22,95%CI:1.10~1.36,P=0.003),铋剂四联疗法(RR=1.11,95%CI:1.07~1.15,P0.001)]以及芽胞杆菌联合H.pylori常规治疗的两种疗程[10 d(RR=1.14,95%CI:1.04~1.24,P=0.006),14 d(RR=1.14,95%CI:1.07~1.21,P0.001)]均提高H.pylori根除率;而亚组分析芽胞杆菌种类中,地衣芽胞杆菌差异有统计学意义(RR=1.14,95%CI:1.10~1.19,P0.001),凝结芽胞杆菌与蜡样芽胞杆菌需扩大样本量进一步统计分析。结论芽胞杆菌联合疗法能有利于提高H.pylori根除率,并降低总不良反应的发生,相对于标准疗法有一定的意义。     

Culture of a Gastric Non‐Helicobacter pylori Helicobacter from the Stomach of a 14‐Year‐Old Girl

Helicobacter felis belongs to the fastidious gastric non‐Helicobacter pylori helicobacter species that are typically found in the stomach of cats and dogs. These bacteria have the potential to colonize the human stomach and are then associated with gastritis, gastroduodenal ulcers, and MALT lymphoma. Strains cultured from the human stomach are rare. Here, we present the first isolation of H. felis from a gastric biopsy specimen of a 14‐year‐old girl who presented with persistent epigastric pain. The strain was cultured using our routine protocol for H. pylori and identified by phylogenetic analyses of partial urease AB and gyrB gene sequences.